Lucamzi
- Product NDC
- 85006-4663
- Requested package NDC
- 85006-4663-1
- 11-digit product format
- 850064663
- Labeler code
- 85006
- Product ID
- 85006-4663_d8337b8e-4cb3-49a8-a95f-723dc3d37ebb
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ranibizumab
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVITREAL
- Labeler
- Valorum Biologics LLC
- Application
- BLA761187
- Marketing category
- BLA
- Marketing start
- 2026-10-27
- Substance
- RANIBIZUMAB
- Active strength
- 10 mg/mL
- Pharmacologic classes
- Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Lucamzi
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| RANIBIZUMAB | 10 mg/mL |
Purple Book Biologic Products#
BLA, Proprietary name, Proper name table| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|
| 761187 | Lucamzi | ranibizumab-blrz | 351(k) Biosimilar | Rx | 2026-10-01 |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 85006-4663-1 | 85006466301 | 1 VIAL, SINGLE-DOSE in 1 CARTON (85006-4663-1) / .5 mL in 1 VIAL, SINGLE-DOSE | 2026-10-27 | No | No | Current |